It is not easy to determine the survival period of postoperative stage IIIA hypofractionated lung adenocarcinoma, and the five-year survival rate is generally only 30%~40%. Since hypofractionated lung adenocarcinoma has a higher probability of recurrence, chemotherapy, radiotherapy and other treatments should be completed as prescribed by the doctor after operation.
Stage IIIA postoperative hypofractionated lung adenocarcinoma is the result of pathological examination after surgery. The five-year survival rate of Stage IIIA lung adenocarcinoma is generally only 30%~40%, and among them, hypofractionated lung adenocarcinoma has a greater degree of malignancy, and its postoperative survival will be even worse.
Hypofractionated cancers have a higher risk of recurrence after surgery, and the length of patient’s survival is related to whether or not the patient has undergone chemotherapy, radiotherapy, immunotherapy, and targeted therapy after surgery, and continued treatment after surgery can help reduce the risk of recurrence after surgery.
If the examination determines that it is stage IIIA postoperative poorly differentiated lung adenocarcinoma, please follow the doctor’s instructions to complete the follow-up treatment.